Magnitude Biosciences

Magnitude Biosciences

Signal active

Organization

Contact Information

Overview

Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.

About

Industries

Biotechnology, Health Care, Pharmaceutical, Fitness

Founded

2018

Employees

11-50

Headquarters locations

Europe

Social

N/A

Profile Resume

Magnitude Biosciences headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Fitness sector. The company focuses on Biotechnology and has secured $96.2M in funding across 80 round(s). With a team of 11-50 employees, Magnitude Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Magnitude Biosciences, raised $591.9K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace David Weinkove

David Weinkove

CEO

imagePlace John O'Brien

John O'Brien

Chief Operating Officer

Funding Rounds

Funding rounds

5

Investors

4

Lead Investors

0

Total Funding Amount

$1.2M

Details

4

Magnitude Biosciences has raised a total of $1.2M in funding over 4 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Seed194.7K
2019Seed291.1K
2020Seed125.0K
2022Seed

Investors

Magnitude Biosciences is funded by 13 investors.

Investor NameLead InvestorFunding RoundPartners
North East Innovation Fund-FUNDING ROUND - North East Innovation Fund591.9K
Northstar Ventures-FUNDING ROUND - Northstar Ventures591.9K
Magnitude Biosciences-FUNDING ROUND - Magnitude Biosciences591.9K
Saker Capital-FUNDING ROUND - Saker Capital591.9K

Recent Activity

There is no recent news or activity for this profile.